In conclusion, the identification of TARC, TIMP-3, NID1 and NID2 using SOMAscan combined with immunoassay validation placed these four proteins as possible biomarker candidates of ALS. The gene discussed is NID2; the disease is amyotrophic lateral sclerosis.